Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsors and Collaborators: |
Sykehuset Asker og Baerum University of Oslo |
---|---|
Information provided by: | Sykehuset Asker og Baerum |
ClinicalTrials.gov Identifier: | NCT00506818 |
Cognitive and emotional symptoms are often sees in the acute phase of a stroke. The prevalence of such symptoms later and the mechanisms explaining the symptoms are not fully known. The causes of poststroke dementia are likely to be multifactorial (Cerebrovascular Diseases 2006). We want to include all patients with first ever stroke without significant cognitive decline prior to the stroke (IQCODE cut-off 3,7) and follow them up for one year. At baseline we will make stroke classifications, measure neurological deficits according to NIHSS, evaluate cognitive and emotional function and make registrations of vascular risk factors, including precerebral color duplex scan with measurement of IMT in CCA. We will then randomize the patients into multifactorial vascular-risk-factor-intervention in the hospital or care as usual in the primary health care. 8-12 months after stroke onset, survivors will undergo new examinations to evaluate neurological, cognitive and emotional functions, as well as MRI and SPECT.
Condition | Intervention |
---|---|
Stroke Cognitive Impairment Emotional Symptoms Vascular Risk-Factors Vascular Dementia |
Other: Multifactorial vascular-risk-factor-intervention |
Study Type: | Interventional |
Study Design: | Prevention, Randomized, Single Blind, Parallel Assignment, Efficacy Study |
Official Title: | Cognitive and Emotional Impairment After Stroke |
Estimated Enrollment: | 300 |
Study Start Date: | February 2007 |
Estimated Study Completion Date: | January 2010 |
Arms | Assigned Interventions |
---|---|
2: No Intervention
Care as usual in the primary health care
|
Other: Multifactorial vascular-risk-factor-intervention |
Genders Eligible for Study: | Both |
Inclusion Criteria:
Exclusion Criteria:
Contact: Hege Ihle-Hansen, MD | +47 67809400 | hege.ihle-hansen@sabhf.no |
Contact: Brynjar Fure, PhD | +47 67809400 | bryfure@online.no |
Norway, 1309 | |
Sykehuset Asker og Baerum HF | Recruiting |
Pb 83, 1309, Norway, RUD | |
Contact: Hege Ihle-Hansen, MD +47 67809400 hege.ihle-hansen@sabhf.no | |
Contact: Brynjar Fure, PhD +47 67809400 bryfure@online.no | |
Principal Investigator: Hege Ihle-Hansen, MD |
Principal Investigator: | Hege Ihle-Hansen, MD | Sykehuset Asker og Baerum |
Study ID Numbers: | 1.2006.2076(REK), 1.2006.2076(REK), 16307(NSD) |
Study First Received: | July 23, 2007 |
Last Updated: | July 23, 2007 |
ClinicalTrials.gov Identifier: | NCT00506818 |
Health Authority: | Norway: The National Committees for Research Ethics in Norway; Norway: Norwegian Social Science Data Services |
Arterial Occlusive Diseases Cerebral Infarction Stroke Vascular Diseases Central Nervous System Diseases Ischemia Arteriosclerosis Brain Diseases Cerebrovascular Disorders Intracranial Arterial Diseases |
Cognition Disorders Intracranial Arteriosclerosis Delirium, Dementia, Amnestic, Cognitive Disorders Mental Disorders Brain Ischemia Dementia, Vascular Brain Infarction Dementia Infarction Delirium |
Nervous System Diseases Cardiovascular Diseases |